Rayner Newsroom

The first UK implantation of a Multifocal Toric IOL (Rayner M-flex^®T took place on Wednesday 9th January 2008 at the Wellington Hospital, London. Surgery was successfully performed by London ophthalmologist, Mr. Simon Levy.

The development of the Rayner M-flex®T Multifocal Toric IOL is another world first for the company and marks a significant leap forward in refractive and cataract surgery.

London-based Consultant Ophthalmic Surgeon Mr Charles Claoué, reported the recent case of an implantation of a Rayner custom-made +42D Rayner C-flex® intraocular lens.

“Patient X, aged 57 came for refractive surgery knowing he was long-sighted having been refused by a high-street laser chain. He was aware of a right corneal scar and life-long poor vision. On examination, uncorrected visual acuities were <6/60 and BSCVA 6/18 right +15.75/-3@160 and left 6/18 +13.00/-1@125. 

Rayner today announced from the XXV Congress of the European Society of Cataract and Refractive Surgeons (ESCRS) the launch of a new lens in the European and Asian markets: the Sulcoflex® Single Piece intraocular lens (IOL).

This morning, Rayner hosted another very successful Breakfast Seminar chaired by Mr. Charles Claoué, London, UK and co-moderated with Mr. Ashok Vyas, Scarborough, UK

Delegates found all the presentations, given by an internationally renowned faculty, both very interesting and highly informative.

Rayner Intraocular Lenses Ltd proudly announced today that it received PMA (pre-market approval) for the C-flex® injectable intraocular lens from the US Food and Drug Administration (FDA).

During the sessions of the annual CIMO Course, Dr Julián Cezón reported excellent results with his first two Rayner M-flex^®T lenses in two patients.

A recently published paper (abstracted below) entitled Prospective, non-randomised, long term clinical evaluation of a foldable hydrophilic single piece intraocular lens: results of the Centerflex® FDA study (K A Becker, M Martin, T M Rabsilber, B B Entz, A J Reuland, G U Auffarth [Br J Ophthalmol 2006;90:971-974]) has shown excellent functional results for the Rayner Centerflex® IOL, with low values for endothelial cell loss and inflammatory signs, and no anterior capsular shrinkage.

This morning, Rayner hosted a very successful Breakfast Seminar chaired 
by Mr. Charles Claoué (London, UK) with an internationally renowned faculty. 
Many aspects of cataract surgery and the current status of IOLs were discussed and delegates were also introduced to some exciting new possibilities in IOL technology.

“If I have seen further it is by standing on the shoulders of giants” 
Sir Isaac Newton

This afternoon, in collaboration with UKISCRS and St. Thomas’ Hospital, Lonndon, Rayner hosted a seminar entitled “On the shoulders of Ridley” – a celebration – on the centenary of his birth – of the innovative genius of the late Sir Harold Ridley (1906-2000): his life and work and the subsequent development and future of his great invention, the intraocular lens.

Rayner is pleased to announce the implantation of the first Rayner C-flex^® monofocal IOL with an aspheric correction.

Surgery was performed by Mr. Charles Claoué (London, UK) with very encouraging results.

The Rayner C-flex^® Aspheric IOL (and the Superflex® Aspheric IOL) are based on aberration-neutral optic technology.